# FDA decision: Venglustat by Sanofi (in 2026): prediction market odds

> Live prediction market odds for "FDA decision: Venglustat by Sanofi (in 2026)". a full approval or an accelerated approval leads at 79%. $1K has traded across 1 outcome on Kalshi. The market is expected to resolve by Jan 1, 2027.

- Status: Live
- Prices updated: 2026-11-13T07:06:40Z (21 min ago)
- Expected to resolve by: Jan 1, 2027
- Volume traded: $1K
- Venues: Kalshi
- Category: economics

## Odds by outcome

| Outcome | Chance | Kalshi |
| --- | --- | --- |
| a full approval or an accelerated approval | 79% | 79% |

"Chance" blends the venues' prices, weighted by volume. Venue columns are each venue's own price.

## How each venue settles

- Kalshi: Kalshi (CFTC-regulated exchange). Sources: [AppliedXL](https://www.appliedxl.com/).

## Links

- Full page with charts and order books: https://thepredictionmarkets.com/odds/fda-decision-venglustat-by-sanofi-in-2026
- Trade on Kalshi: https://kalshi.com/markets/kxvenglustat?utm_source=thepredictionmarkets.com&utm_medium=referral
- API (free key): https://api.thepredictionmarkets.com/api/public/v1/events/fda-decision-venglustat-by-sanofi-in-2026

---
Source: The Prediction Markets (https://thepredictionmarkets.com), which compares Kalshi and Polymarket prices side by side. Prices are market-implied probabilities, not forecasts by TPM. Cite the page URL and the "Prices updated" time.